Taiwan FDA registration bd88f7993d0136d9d26ada21f26b5b54

Encore Early Pregnancy (urine) testing system

TW: 安可早孕(尿液)測試系統
Taiwan flagTaiwan·Risk Class 2·ACON BIOTECH (HANGZHOU) CO., LTD.·Registered Jan 17, 2007 – Jan 17, 2012Cancelled
Registration details
Analysis ID
bd88f7993d0136d9d26ada21f26b5b54
Customs Code
DHA04200033600
Company information
Manufacturer Country
China
Authorized Representative
MIN JIER FIRM
Product details
Intended Use
Immunoassay was used to qualitatively analyze human chorionic gonadal hormone (hCG) in female urine in vitro. It can be detected when the concentration of hCG in the urine is as high as 25 mIU/mL.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1155 Human chorionic gonadotropin testing system
Import Information
Input;; Chinese goods
Dates and status
Registration Date
Jan 17, 2007
Expiry Date
Jan 17, 2012
Cancellation Date
Apr 30, 2014
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for Encore Early Pregnancy (urine) testing system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number bd88f7993d0136d9d26ada21f26b5b54 and manufactured by ACON BIOTECH (HANGZHOU) CO., LTD.. The authorized representative in Taiwan is MIN JIER FIRM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices